Correlation Between Tredegar and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Tredegar and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tredegar and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tredegar and Processa Pharmaceuticals, you can compare the effects of market volatilities on Tredegar and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tredegar with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tredegar and Processa Pharmaceuticals.

Diversification Opportunities for Tredegar and Processa Pharmaceuticals

0.1

Correlation Coefficient

Tredegar  Processa Pharmaceuticals

Average diversification

The 3 months correlation between Tredegar and Processa is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Tredegar and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Tredegar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tredegar are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Tredegar i.e., Tredegar and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Tredegar and Processa Pharmaceuticals

Allowing for the 90-day total investment horizon Tredegar is expected to generate 0.28 times more return on investment than Processa Pharmaceuticals. However, Tredegar is 3.6 times less risky than Processa Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  825.00  in Tredegar on May 28, 2025 and sell it today you would lose (48.00) from holding Tredegar or give up 5.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Tredegar  vs.  Processa Pharmaceuticals

Tredegar

Risk-Adjusted Performance

Weakest

Over the last 90 days Tredegar has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Tredegar is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Processa Pharmaceuticals

Risk-Adjusted Performance

Weakest

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Tredegar and Processa Pharmaceuticals

The main advantage of trading using opposite Tredegar and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tredegar position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Tredegar and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.